76344-81-5Relevant academic research and scientific papers
PAK1 INHIBITORS AND USES THEREOF
-
Paragraph 0086, (2017/12/13)
Methods are disclosed for treating acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) using compounds that inhibit p21 protein (Cdc42/Rac)-activated kinase (PAKl).
5-Aryl-4-isoxazolecarboxylate-safening agents
-
, (2008/06/13)
The invention relates to the safening of crop plants to the use of herbicides using a 5-aryl-4-isoxazolecarboxylate or composition containing such compounds to reduce the herbicidal injury to treated crop plants. The invention is also concerned with novel compositions which comprise an acetanilide herbicide and a 5-aryl-4-isoxazolecarboxylate.
